Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CVNA | IBKR |
|---|---|---|
| Price | $64.04 | $90.05 |
| Change today | ▲ 0.14% | ▼ 1.65% |
| Market cap | $46.10B | $40.80B |
| Return, 3 months | -5.7% | -2.9% |
| Return, year to date | -24.1% | +40.4% |
| Return, 1 year | -14.6% | +40.3% |
| P/E (TTM) | 33.9 | 35.7 |
| P/B | 11.4 | 6.9 |
| P/E percentile vs own 5y | 57th | 91st |
| Dividend yield | – | 0.36% |
| Revenue growth (YoY, latest qtr) | +52.4% | +21.3% |
| Net profit growth (YoY) | +66.6% | +33.0% |
| Gross margin | 19.4% | 90.2% |
| Operating margin | 8.9% | 86.5% |
| Net margin | 6.3% | 10.2% |
| Return on equity | 54.5% | 21.0% |
| Analyst target vs. price | +33.4% | +21.5% |
| Analyst buy share | 76% | 67% |
| RSI (14) | 36 | 53 |
| 30-day volatility | 55.1% | 41.1% |
| Max drawdown, 1 year | -41.2% | -18.7% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.